Aug 20, 2015

New Publication from Xiang Lab in J Gene Med

"Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity"

Jul 2, 2015

New Publication from Xiang Lab in Cell Mol Immunol

"Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44+CD62Lhigh IL-7R+ CTLs with up- and downregulation of anti- and pro-apoptosis genes"

May 15, 2015

New Publication from Xiang Lab in Tumori

"Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells via increased dendritic cell maturation"

Apr 28, 2015

Dr. Jim Xiang awarded a Prostate Cancer Fight Foundation Grant

Dr. Jim Xiang was awarded a prostate cancer grant from the Swift Current chapter of the TELUS Motorcycle Ride for Dad to carry out a project called: “Novel HER2-specific exosome-targeted T cell vaccine for HER2-positive prostate cancer bone metastasis”.

Apr 1, 2015

Dr. Keith Bonham awarded a Saskatchewan Cancer Agency Grant

Dr. Keith Bonham (co-PI: Dr. Franco Vizeacoumar) was awarded a 2-year grant from the Saskatchewan Cancer Agency. Title: 'A systematic approach to define chemical genetic interactions of DHAC inhibitors in breast cancer cells.'